Screener
Krystal Biotech, Inc. KRYS Interest Expense
Interest Expense at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The source filing: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 7:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001711279-26-000043
| (in thousands, except per share data) | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Total operating expenses | 62,668 | 51,931 |
| Income from operations | 53,689 | 36,252 |
| Other income | ||
| Interest and other income, net | 7,753 | 7,345 |
| Income before income taxes | 61,442 | 43,597 |
| Income tax expense | (5,510) | (7,864) |
| Net income | 55,932 | 35,733 |
| Unrealized (loss) gain on available-for-sale securities | (1,577) | 344 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Krystal Biotech, Inc.'s interest expense?
- Krystal Biotech, Inc. (KRYS) reported interest expense of $7.75M in Q1 2026.
- How has Krystal Biotech, Inc.'s interest expense changed year-over-year?
- Krystal Biotech, Inc.'s interest expense increased by 5.6% year-over-year, from $7.35M to $7.75M.
- What is the long-term trend for Krystal Biotech, Inc.'s interest expense?
- Over 3 years (2021 to 2025), Krystal Biotech, Inc.'s interest expense has grown at a 166.6% compound annual growth rate (CAGR), from $1.49M to $28.27M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Krystal Biotech, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude